Suspended

BPV échoguidéFeasibility of the Use of Ultrasound-guided Paravertebral Catheterisation for the Analgesic Management of Thoracotomy

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

ultrasoundguided paravertebral catheter

Device
Who is being recruted

Neurologic Manifestations+4

+ Pain

+ Pathologic Processes

From 18 to 80 Years
+5 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Phase 2
Interventional
Study Start: April 2013
See protocol details

Summary

Principal SponsorCentre Jean Perrin
Last updated: March 20, 2014
Sourced from a government-validated database.Claim as a partner

Study start date: April 1, 2013

Actual date on which the first participant was enrolled.

Prospective followed of cohort including consecutive patients, all receiving the same technique of anesthesia and analgesia: Preoperative para-vertebral catheterisation on the surgery side. Preoperative test of the efficiency of para-vertebral block. Conventional general anesthesia. Conventional rescue postoperative analgesia. Systematic radiographic control with injection of contrast product into the para-vertebral catheter. Conventional postoperative monitoring.

NCT01842698
Principal SponsorCentre Jean Perrin
Last updated: March 20, 2014
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

60 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 80 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Neurologic ManifestationsPainPathologic ProcessesPostoperative ComplicationsSigns and SymptomsPathological Conditions, Signs and SymptomsPain, Postoperative

Criteria

2 inclusion criteria required to participate
Aged 18 to 80 years
Patients undergoing programmed lateral or posterolateral thoracotomy, regardless of indication
3 exclusion criteria prevent from participating
Contraindications to the products of the study
Specific clinical contexts including neoplasia in terminal phase or palliative phase
Surgery performed in the emergency

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
ultrasoundguided paravertebral catheter

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Centre de lautte contre le cancer - Centre Jean Perrin

Clermont-Ferrand, FranceOpen Centre de lautte contre le cancer - Centre Jean Perrin in Google Maps
SuspendedOne Study Center